In what manner is our understanding of serogenetics and cytogenetics useful in reproductive biology? What are the major ethical issues involved in reproductive technology?
15 marks · directive: Discuss
The core of a good answer
Serogenetics (inherited blood group and protein antigens) helps predict and prevent maternal-foetal incompatibility such as Rh disease, and cytogenetics (chromosome study) diagnoses causes of infertility, recurrent pregnancy loss and foetal trisomies; reproductive technologies built on them raise ethical issues of consent, sex selection, embryo status, commodification in surrogacy, genetic modification and unequal access.
An outline written by upsc.help, not an official UPSC answer; every fact checked by a separate review. How we work
What the question asks
Two parts: first the applications of serogenetics and cytogenetics to fertility, pregnancy and prenatal diagnosis with examples; then a balanced list of ethical concerns, ideally with Indian law. Equal weight to both parts.
Answer outline
Introduction
Reproductive biology deals with gametes, conception, pregnancy and foetal development; blood group genetics and chromosome analysis are two older genetic tools that remain central to clinical reproduction.
Serogenetics in reproduction
- Rh incompatibility: an Rh negative mother sensitised by Rh positive foetal cells forms anti-D IgG that crosses the placenta in later pregnancies and destroys foetal red cells (haemolytic disease of the foetus and newborn); anti-D immunoglobulin prophylaxis prevents sensitisation.
- ABO incompatibility: usually mild haemolytic disease, mostly in group O mothers; it also reduces the risk of Rh sensitisation.
Cytogenetics in reproduction
- Karyotyping of infertile couples: Klinefelter syndrome (47,XXY) causing azoospermia; Turner syndrome (45,X) causing primary amenorrhoea.
- Balanced translocations (for example Robertsonian) in a parent are a rare cause of recurrent pregnancy loss.
- Y chromosome microdeletions in male infertility, causing azoospermia or oligozoospermia.
- Prenatal diagnosis by chorionic villus sampling (first trimester) and amniocentesis (second trimester), with FISH, for trisomies 21, 18 and 13.
- Preimplantation genetic testing in IVF embryos; cell free foetal DNA screening of maternal blood.
Ethical issues in reproductive technology
- Sex selection and female foeticide through misuse of prenatal diagnosis.
- Informed consent and counselling for invasive tests, IVF and gamete donation; donor anonymity and the child's right to know origins.
- Status of embryos: creation, storage, destruction and research use.
- Surrogacy: exploitation and commodification of poor women, and nationality of children, as in the Baby Manji case (2008), where the baby held neither Indian nor Japanese nationality.
- Eugenic concerns and 'designer babies'; germline editing, as in He Jiankui's November 2018 announcement of CRISPR edited twins.
- Equity: high costs limit access; stigma of infertility falls on women.
- Privacy of genetic information and possible discrimination.
Conclusion
Serogenetics and cytogenetics have made pregnancy safer and infertility treatable, but their power must be governed by law and ethics that protect women, children and donors.
Examples and data to cite
- Pre-Conception and Pre-Natal Diagnostic Techniques (Prohibition of Sex Selection) Act, 1994 (in force 1 January 1996; extended to pre-conception sex selection in 2003) bans sex determination.
- Surrogacy (Regulation) Act, 2021 bans commercial surrogacy and permits only altruistic surrogacy.
- Baby Manji Yamada v. Union of India (2008) reached the Supreme Court and exposed the legal vacuum on surrogacy.
Facts to remember
- Rh disease affects mainly second and later Rh positive pregnancies of a sensitised Rh negative mother.
- Anti-D is given at 28 and 34 weeks and within 48 hours of delivery.
- Common karyotypes: 47,XXY (Klinefelter), 45,X (Turner).